Table 1.
MBL genotype frequencies (%) in CF patients and healthy controls.
CF n = 112 | Controls n = 200 | |||
---|---|---|---|---|
MBL-sufficient genotypes | A/A | HYA/HYA | 10·7 | 6·5 |
HYA/LXA | 10·7 | 13·5 | ||
HYA/LYA | 10·7 | 15·5 | ||
LYA/LYA | 4·5 | 3·5 | ||
LYA/LXA | 12·5 | 13·5 | ||
LXA/LXA | 8·9 | 5·5 | ||
YA/0 | HYA/LYB | 9·8 | 10·0 | |
HYA/LYC | 0·0 | 0·5 | ||
HYA/HYD | 6·3 | 7·5 | ||
LYA/LYB | 4·5 | 6·0 | ||
LYA/LYC | 0·9 | 0·0 | ||
LYA/HYD | 2·7 | 4·0 | ||
MBL-deficient genotypes | XA/0 | LXA/LYB | 4·5 | 5·0 |
LXA/HYD | 8·0 | 1·5 | ||
LXA/LYC | 0·0 | 0·5 | ||
0/0 | LYB/LYB | 1·8 | 3·0 | |
LYB/LYC | 0·9 | 0·0 | ||
LYB/HYD | 0·9 | 1·0 | ||
LYC/HYD | 0·9 | 1·0 | ||
HYD/HYD | 0·9 | 2·0 |